AMGEN, Outperform, GILEAD, Outperform - Gilead and Amgen - Offer Long Term Value
Our relative valuation reiterates GILEAD (GILD) and AMGEN (AMGN) as value buys. While GILD is trading at lowest PE’11, P/C, AMGN trades with a lowest P/B in the Biotech sector. In our report, we have also analyzed upcoming positives and risks in the near and long term. Detailed reports on the company, valuation etc can be made available to registered subscribers or on individual requests. For more detail, please read our report, released on 29th June, 2011 titled, “Gilead and Amgen - Offer Long Term Value”.
COMPANIES MENTIONED
AMGEN, AMGN, GILEAD, GILD,
AMGEN, AMGN, GILEAD, GILD,
